myelin oligodendrocyte glycoprotein peptide Myelin oligodendrocyte glycoprotein is a minor myelin component - NPYpeptide Myelin oligodendrocyte glycoprotein (MOG

NPYpeptide The intricate world of neuroscience often delves into the specific components that maintain the health and function of the central nervous system (CNS). Among these crucial elements is myelin oligodendrocyte glycoprotein (MOG), a significant protein involved in the vital process of myelination. This article will explore the myelin oligodendrocyte glycoprotein peptide, particularly the well-studied MOG (35-55) fragment, its role in research, and its implications in understanding neurological conditions.

Understanding Myelin Oligodendrocyte Glycoprotein (MOG)

Myelin oligodendrocyte glycoprotein is a protein exclusively found in the central nervous system (CNS). It is a member of the immunoglobulin superfamily and plays a critical role in the myelination of nerve fibers.Application Note:Myelin oligodendrocyte glycoprotein (MOG) Control Peptideis suitable for use in ELISA, Western Blot, Dot blot, PCA, and other assays. Myelin acts as an insulator for nerve axons, enabling rapid and efficient transmission of electrical signalsMyelin Oligodendrocyte Glycoprotein Peptide (35-55), Rat, .... Oligodendrocytes are the cells responsible for producing myelin in the CNS. Myelin oligodendrocyte glycoprotein (MOG) is located on the outer surface of the myelin sheath, and its presence is believed to be important for maintaining the integrity and function of these myelin sheaths. While it is considered a minor myelin component, its involvement in neurological processes has made it a significant target for researchMyelin oligodendrocyte glycoprotein: a novel candidate .... Myelin oligodendrocyte glycoprotein is a glycoprotein, meaning it has carbohydrate chains attached to its protein structure, which can influence its interactions and functions.

The Myelin Oligodendrocyte Glycoprotein Peptide (35-55)

The myelin oligodendrocyte glycoprotein peptide (35-55), often referred to as MOG (35-55), is a specific fragment of the myelin oligodendrocyte glycoprotein that has garnered substantial attention in scientific researchMyelin Oligodendrocyte Glycoprotein (MOG 35-55), 25 mg. This particular peptide is known for its ability to reliably induce experimental autoimmune encephalomyelitis (EAE) in rodents. EAE is an animal model widely used to study inflammatory demyelinating diseases of the central nervous system, most notably multiple sclerosis (MS).

When administered to susceptible animal models, such as mice and rats, the MOG (35-55) peptide triggers an immune response directed against the animal's own myelin.MOG (91-108) peptide - SDEGGYTCFFRDHSYQEE This response leads to inflammation and demyelination within the CNS, mimicking key pathological features of multiple sclerosis. Studies have shown that a single injection of this peptide can produce a relapsing-remitting neurological disease in rodents, characterized by significant plaque-like demyelination. This makes the MOG (35-55) peptide an invaluable tool for researchers investigating the mechanisms of autoimmune attacks on the CNS and for evaluating potential therapeutic interventions.

Applications and Research Significance

The MOG (35-55) peptide serves as a crucial antigen in the study of autoimmune neurological disorders. Its ability to induce EAE allows scientists to:

* Investigate the immune mechanisms underlying demyelination, including the role of T cells and B cells. The MOG (35-55) peptide is known to induce a strong Th1 cytokine response and high levels of IgG antibodies2018年1月4日—Compositions for the treatment or prevention of multiple sclerosis are provided. In some embodiments, the composition comprises an isolated ....

* Develop and test new treatments for myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and multiple sclerosisA myelin oligodendrocyte glycoprotein peptide induces .... By employing animal models treated with the myelin oligodendrocyte glycoprotein (MOG) peptide 35-55, researchers can assess the efficacy of immunomodulatory drugs, neuroprotective agents, and myelin repair strategies.

* Understand the diagnostic relevance of MOG antibodies. While the MOG peptide is used in research, MOG antibodies are also clinically relevant biomarkers for diagnosing certain neurological conditions. For example, MOGAD disorder and multiple sclerosis share some overlapping clinical and radiological features, making antibody testing crucial for differential diagnosis. MOG Peptide is used for blocking the activity of MOG antibody in certain experimental settings, further highlighting the intricate relationship between the peptide and its corresponding antibody.

Beyond the MOG (35-55) fragment, other Myelin oligodendrocyte glycoprotein (MOG) peptides, such as MOG (91-108) peptide, are also studied for their potential involvement in different aspects of CNS biology and disease. The availability of various purified myelin oligodendrocyte glycoprotein fragments and related peptides from specialized suppliers facilitates diverse research avenues.The MouseMyelin-oligodendrocyte glycoprotein Peptideis a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays.

Variations and Considerations

Researchers select specific forms of peptides for their experiments. For instance, the MOG (35-55) peptide is available in different salt forms, such as acetate, and with varying modifications like amidation or trifluoroacetic acid (TFA) treatment, which can influence solubility and stability. For example, MOG (35-55) TFA is a common commercially available form. Product specifications often detail parameters like molecular weight; for instance, one form of Myelin oligodendrocyte glycoprotein peptide (35-55), rat, mouse has a molecular weight of approximately 2582.A predominant response tomyelin oligodendrocyte glycoprotein (MOG) was recently observed in patients with multiple sclerosis (MS). To study the possible ...00 g/mol.Thispeptideinduces severe chronic experimental autoimmune encephalomyelitis in transgenic mice.

The study of myelin oligodendrocyte glycoprotein and its associated peptides is a dynamic field. With continued research, our understanding of these molecules' roles in both health and disease, including conditions like myelin oligodendrocyte glycoprotein antibody-associated disease, is continually advancingMyelin oligodendrocyte glycoprotein (MOG) is a member of the immunoglobulin superfamily and is expressed exclusively in the central nervous system.. The MOG (35-55) peptide, in particular, remains a cornerstone in the preclinical investigation of demyelinating diseases, offering vital insights for the development of future therapiesMyelin Oligodendrocyte Glycoprotein (MOG) Antibody, IgG by CBA-IFA ....